Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Renovaro Biosciences ( (RENB) ) has provided an update.
Renovaro Inc. received a notice from Nasdaq on July 7, 2025, for non-compliance with the requirement to hold an annual meeting of shareholders within twelve months of the fiscal year-end. Nasdaq accepted the company’s plan to regain compliance, granting an extension until October 31, 2025, to hold the meeting.
More about Renovaro Biosciences
Average Trading Volume: 3,669,929
Technical Sentiment Signal: Sell
Current Market Cap: $57.13M
See more insights into RENB stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money